Division of Biology, California Institute of Technology, Pasadena, 91125, USA.
Cell Host Microbe. 2012 Aug 16;12(2):132-8. doi: 10.1016/j.chom.2012.07.005.
Human immunodeficienty virus (HIV) infection is suppressed but not eliminated by antiretroviral drugs. Viral persistence in the face of therapy has been explained by viral latency, lowered effectiveness of drugs in some anatomical sites and cell types, and cell-to-cell spread. These mechanisms allow for drug-sensitive virus to persist despite treatment. Understanding the persistence mechanism at work at different times after infection, including the time of initial infection immediately following transmission when reservoirs are first formed, will reveal if we are at the limit of what can be achieved with the current therapy paradigm of suppressing ongoing virus replication with drugs. We discuss some of the possible reasons why HIV persists at different points on the infection timeline, focusing on the role ongoing replication may have in maintaining the infection despite drugs at early times postexposure.
人类免疫缺陷病毒(HIV)感染虽然可以通过抗逆转录病毒药物得到抑制,但不能被完全清除。病毒在治疗中的持续存在可以通过病毒潜伏、某些解剖部位和细胞类型药物效果降低以及细胞间传播来解释。这些机制允许药物敏感病毒在治疗的情况下持续存在。了解感染后不同时间的持续存在机制,包括在最初传播后立即形成储存库的初始感染时间,将揭示我们是否已经达到了目前用药物抑制持续病毒复制的治疗范式所能达到的极限。我们讨论了 HIV 在感染时间线上的不同时间点持续存在的一些可能原因,重点关注了在接触后早期,持续复制可能在药物的作用下对维持感染所起的作用。